Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Coronary Artery Disease V: Interprofessional Care

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...

Venous Thrombosis III: Interprofessional Care

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Beta-Blockers After Myocardial Infarction With Preserved and Mildly Reduced Ejection Fraction: A Meta-Analysis With Trial Sequential Analysis.

European journal of clinical investigation·2026

Same author

Subcutaneous Adipose Tissue as a Metabolic Mirror: Transcriptomic Insights Into Glycaemic Dysregulation.

European journal of clinical investigation·2026

Same author

CAPIRE score predicts long-term major cardiac events.

The international journal of cardiovascular imaging·2026

Same author

From biology to imaging: Rethinking vulnerable plaques in coronary artery disease.

European journal of clinical investigation·2026

Same author

Senescent obesity signature in breast cancer: a paradigm of reverse cardio-oncology.

European heart journal·2026

Same author

Artery tertiary lymphoid organs, neuro-immune interaction and their mediators in atherosclerosis.

Basic research in cardiology·2026

Search research articles

Related Experiment Video

Updated: May 24, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Statins and stent thrombosis.

Vincent Braunersreuther¹, François Mach, Fabrizio Montecucco

¹Division of Cardiology, Faculty of Medicine, Foundation for Medical Researches, Geneva University, Switzerland. vincent.braunersreuther@unige.ch

Swiss Medical Weekly

|February 21, 2012

Summary

This summary is machine-generated.

Stent thrombosis, a serious complication, may be reduced by statins. Further research is needed to confirm their effectiveness and explore statin-eluting stents for preventing stent thrombosis.

Related Experiment Videos

Last Updated: May 24, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Area of Science:

Cardiovascular Medicine
Interventional Cardiology
Pharmacology

Background:

Stent thrombosis is a rare but severe complication following stent implantation in atherosclerotic arteries.
Updated diagnostic criteria for stent thrombosis emphasize time and probability, complicating clinical trial assessments.
Stent thrombosis is linked to adverse outcomes like death, acute coronary syndromes, and arrhythmias.

Purpose of the Study:

To review the current understanding of stent thrombosis and the potential role of statins in its prevention.
To highlight the need for further research, particularly randomized clinical trials with definitive diagnostic criteria.
To explore the unexplored use of statins in patients with stents in non-coronary arteries and the potential of statin-eluting stents.

Main Methods:

Review of existing literature on stent thrombosis and statin use.
Analysis of updated diagnostic criteria for stent thrombosis.
Discussion of preliminary findings and future research directions.

Main Results:

Statins show potential in reducing coronary stent thrombosis incidence in humans.
Definitive randomized clinical trials are lacking to confirm statin efficacy for stent thrombosis.
The use of statins in non-coronary stenting and the efficacy of statin-eluting stents remain largely unexplored.

Conclusions:

Current evidence suggests statins may help prevent stent thrombosis, but definitive clinical trials are required.
Further investigation into statin pleiotropic effects is needed to understand their role in preventing stent complications.
Caution is advised regarding statin use for stent thrombosis prevention due to limited definitive data.